0.00Open0.54Pre Close0 Volume5 Open Interest71.00Strike Price0.00Turnover97.64%IV11.05%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.54Extrinsic Value100Contract SizeAmericanOptions Type-0.1272Delta0.0256Gamma146.69Leverage Ratio-0.2055Theta-0.0011Rho-18.66Eff Leverage0.0174Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet